drugset / Trial / NCT00274521

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521

Phase 3 Completed 108 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The study was designed to determine whether tiotropium inhalation capsules, compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation. In addition, assessments of the effect of tiotropium on dyspnea and quality of life following pulmonary rehabilitation were taken.

Timeline

Start
2001-05
Primary completion
2003-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 18 ug Inhaled